http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201105341-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
| filingDate | 2010-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1ca9f698c733361011489a64e10518c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0874360170740b1ebe50cf9e14a29173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32bd18786c320b4bb874052f22ae20a |
| publicationDate | 2011-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201105341-A |
| titleOfInvention | Pharmacetical composition for inhibitng pain |
| abstract | Provided is a pharmaceutical composition comprising a cross-linked hyaluronic acid and a pharmaceutical acceptable carrier for inhibiting pain of joint disease. The cross-linked hyaluronic acid is obtained by cyclizing the double bond of the cinnamic acid moiety of the partially amidated hyaluronic acid represented by the following formula (1): [Ar-CH=CH-COO-(CH2)n-NH-]m-HA (1) (wherein, Ar represents an optionally substituted phenyl group, n represents 2 or 3, HA represents the carboxyl residue of hyaluronic acid, m represents the ratio of amidated carboxy group to total carboxyl group of hyaluronic acid, m is 3 to 50% of total carboxyl group). The pharmaceutical composition of this invention is a medicine administrated to joint, exhibiting analgesic effect rapidly after administration, and only one administration being able to maintain an extremely long period of the effect to human joint disease, comparing to the conventional several times administration. |
| priorityDate | 2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.